|  Special Purpose Formulas 1. Cancer Epidemiol Biomarkers Prev. 1994;3(7):591-595. 2. Int J Obes Relat Metab Disord. 1998;22(3):227-229. 3. Baba S et al. Am J Clin Nutr. 2007 Mar;85(3):709-17. 4. Hypertension. 2005 Aug;46(2):398-405. 5. Heart. 2006 Jan;92(1):119-20. 6. Free Radic Biol Med. 2004; 37: 1351–1359. 7. Sies H et al. Am J Clin Nutr. 2005 Jan;81(1 Suppl):304S-312S 8. JAMA. 2007 Jul 4;298(1):49-60. 9. J Nutr. 2007 Jun;137(6):1436-41. 10. Nutrition. 2007 Apr;23(4):332-41. 11. Ann Nutr Metab. 2005 May-Jun;49(3):141-8. 12. Nature Med. 2003 Mar;9(3):294-9. 13. Diabetes Care. 2006 Sep;29(9):2064-71. 14. Ann N Y Acad Sci. 2005 Jun;1043:777-83. 15. Diabetes Metab Res Rev. 2004 Jul-Aug;20(4):330-6. 16. Diabetes. 2003 Aug;52(8):2110-20. 17. Environ. 2003 Mar 12;2003(10):PE6. 18. Nat Med. 2003 Mar;9(3):294-9. 19. Acta Diabetol. 2001;38(3):135-8. 20. Exp Clin Endocrinol Diabetes. 2001;109(6):330-6. 21. Diabetes Care. 2006 Sep;29(9):2064-71 22. Diabetes Care. 2003 Dec;26(12):3215-8. 23. Diabetes Obes Metab. 2007 Nov;9(6):895-901. 24. J Trace Elem Med Biol. 2006;20(1):33-9. 25. Eur J Immunol. 2005 Feb;35(2):584-92. 26. Ann Intern Med. 2004 Jan 6;140(1):1-8. 27. J Nutr Biochem. 2002 Dec;13(12):717-26. 28. Am J Clin Nutr. 2003 Oct;78(4):728-33. 29. Med Hypotheses. 2005;64(4):848-53. 30. BMC Pharmacol. 2004 Aug;4(1):18. 31. Neurology. 2004 Dec 28;63(12):2240-4. 32. Int J Clin Pharmacol Ther. 2000 Sep;38(9):430-5. 33. Altern Med Rev. 2001 Apr;6(2):207-9. 34. J Immunol. 2004 Jan 1;172(1):79-87. 35. Biol Pharm Bull. 2002 Sep;25(9):1197-202. 36. Exp Biol Med. 2004 Mar;229(3):247-54. 37. JAMA. 1997 Dec 10;278(22):1815-22. 38. Expert Opin Investi Drugs. 2004 Jul;13(7)743-62. 39. Exp Biol Med. 2004 Mar;229(3):247-54. 40. Biol Pharm Bull. 2002 Sep;25(9):1197-202. 41. Indian J Exp Biol. 1999 Feb;37(2):124-30. 42. Carcinogenesis. 1995 Sep;16(9):2057-62. 43. J Agric Food Chem. 2004 Aug 11;52(16):5004-10. 44. Food Chem Toxicol. 2001 Feb;39(2):109-17. 45. Biofactors. 2000;13(1-4):161-6. 46. J Food Prot. 2000 Oct;63(10):1359-68. 47. Plant Foods Hum Nutr. 1999;53(2):169-74. 48. Carcinogenesis. 1998 Oct;19(10):1821-7. 49. J Nutr. 1996 May;126(5):1475-80. 50. Inflamm Res. 1996 Nov;45(11):546-9. 51. Br J Pharmacol. 1999 Nov;128(5):999-1010. 52. Planta Med. 1998 Aug;64(6):541-5. 53. Carcinogenesis. 1995 Aug;16(8):1955-61. 54. Artery. 1995; 21(6):312-6. 55. Hepatol Res. 2006 Mar;34(3):199-206; 56. World J Gastroenterol. 2003 Apr;9(4):791-4. 57. Biochem Pharmacol. 1994 Aug 3;48(3):621-4. 58. Alcohol. 1999 Feb; 17(2):163-8. 59. Fiziol Zh. 1996; 42(12):65-72. 60. Neuroreport. 1999 Jan 3;10(8):1799-801. 61. J Pharm Pharmacol. 1990 Aug;42(8):553-7. 62. Folia Haematol Int Mag Klin Morphol Blutforsch.1988;115(4):447-9. 63. J Pharm Pharmacol. 1987 Jun;39(6):459-65. 64. J Pharm Pharmacol. 986 Sep;38(9):709-12. 66. Am J Med. 1994 Sep 26;97(3A):5S-13S; discussion 22S-28S. 67. Proc Natl Acad Sci USA. 1993 Sep 1;90(17):7915-22. 68. Science. 1997 Oct 17;278(5337):407-11. 69. Hum Genet. 1996 Mar;97(3):319-23. 70. Cancer Sci. 2004 Apr;95(4):290-9. 71. Carcinogenesis. 1995 Apr;16(4):861-7. 72. Proc Natl Acad Sci USA. 1990 Oct;87(19):7777-81. 73. Environ Mol Mutagen. 1997, 30(4): 468-74. 74. Environ Mol Mutagen. 1996, 27(3): 211-8. 75. Environ Mol Mutagen. 1989;16:78-84. 76. J Biol Chem. 1997;272(32):19663-6. 77. Mutation Res. 1989;214:41-46. 78. Proc Natl Acad Sci. 1988;85:6465. 79. Biochim Biophys Acta. 2000;1487(2-3):113-27. 80. Toxicology. 2000;155(1-5):63-7. 81. Zhonghua Yi Xue Za Zhi. (Taipei) 2001;64(5):259-270. 82. Mutat Res. 2003 Feb-Mar;523-524:209-16. 83. Biosci Biotechnol Biochem. 2007 Apr;71(4):916-25 84. J Nutr Sci Vitaminol (Tokyo). 2006 Dec;52(6):457-66. 85. Altern Ther Health Med. 2001 May-Jun;7(3):79-91. 86. Glycoconj J. 1994 Dec;11(6):527-32. 87. J Natl Cancer Inst. 1992 Mar 18;84(6):438-42. 88. Paper presented at: International Conference on Diet and Prevention of Cancer; May 1999; Tampere, Finland. 89. Prostate Cancer Prostatic Dis. 2003;6(4):301-4. 90. J Natl Cancer Inst. 2002 Dec 18;94(24):1854-62. 91. Neoplasia. 2007 Aug;9(8):662-70. 92. Pharmaceutical enzyme properties and assay methods. Ghent: Scientific Publishing. 1978: p 34-35, 45, 57-58, 70. 93. US Pharmacopoeia XXII. Rockville, MD: US Pharmacopeia Convention. 1990. 94. Dixon M, Webb EC. Enzymes. 3rd Edition. New York: Academic Press. 1979: p 28-29, 40, 860-861. 95. Dig Dis Sci. 1982; 27:143-148. 96. J Nutr. 2003 Nov;133(11 Suppl 1):3778S-3784S. 97. Anticancer Res. 1999 Sep-Oct;19(5A):3681-3. 98. Anticancer Res. 1995 Nov-Dec;15(6B):2479-87. 99. Carcinogenesis. 1989 Sep;10(9):1595-8. 100. Life Sci. 1997;61(4):343-54. 101. Posit Health News. 1998 Fall;17:23-5. 102. Biol Pharm Bull. 2004 Jul;27(7):1103-5. 103. J Ethnopharmacol. 2003 Jul;87(1):115-7. 104. Biosci Biotechnol Biochem. 1996 Feb;60(2):204-8. 105. J Nutr Sci Vitaminol (Tokyo). 1999 Dec;45(6):791-5. 106. J Nutr. 2001 Sep;131(9):2242-7. 107. Chem Pharm Bull (Tokyo). 1993 Dec;41(12):2129-31. 108. Diabetes Res Clin Pract. 2006 Aug;73(2):174-7. 109. Biol Pharm Bull. 2006 Mar;29(3):585-7. 110. Life Sci. 2006 Nov 25;79(26):2474-9. |